
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Tuesday Mar 14, 2023
MDT perspectives on established methods for managing DMD
Tuesday Mar 14, 2023
Tuesday Mar 14, 2023
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss established treatments and the importance of the multidisciplinary team in the management of DMD.
The multidisciplinary team:
- Paediatrician: Dr Laura Kauffman, Weissbluth Pediatrics, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA
- Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/

Tuesday Mar 14, 2023
Tuesday Mar 14, 2023
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss novel pharmacological and gene therapies that are available or emerging for the management of DMD.
The multidisciplinary team:
- Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/

Monday Mar 13, 2023
Monday Mar 13, 2023
touchTALKS for touchIMMUNOLOGY
Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.
The expert
- Prof. Tobias Derfuss, University Hospital Basel, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website https://touchimmunologyime.org/pathophysiology_of_ms_and_development_of_treatments/

Monday Mar 13, 2023
Monday Mar 13, 2023
touchTALKS for touchNEUROLOGY
Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.
The expert
- Prof. Tobias Derfuss, University Hospital Basel, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website https://touchneurologyime.org/pathophysiology_of_ms_and_development_of_treatments/

Thursday Mar 09, 2023
Emerging data with immunotherapy in ESCC and potential impact for clinical practice
Thursday Mar 09, 2023
Thursday Mar 09, 2023
touchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
- Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023

Thursday Feb 23, 2023
Improving the alpha-mannosidosis patient journey
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert:
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME.
For further information please visit: touchendocrinologyime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

Thursday Feb 23, 2023
Improving the alpha-mannosidosis patient journey
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchEXPERT OPINIONS for touchRESPIRATORY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert:
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchrespiratoryime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

Thursday Feb 23, 2023
Improving the alpha-mannosidosis patient journey
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchEXPERT OPINIONS for touchNEUROLOGY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert:
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchneurologyime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

Thursday Feb 23, 2023
HER2 testing in colorectal cancer
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchMDT for touchONCOLOGY
A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results.
The multidisciplinary team:
- Medical oncologist: Prof. Andrea Sartore-Bianchi, Niguarda Cancer Center, Milan, Italy
- Pathologist: Dr Evgeny Yakirevich, Rhode Island Hospital, Providence, RI, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

Thursday Feb 23, 2023
Managing treatment side effects in HER2-positive colorectal cancer
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchMDT for touchONCOLOGY
A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting.
The multidisciplinary team:
- Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA
- Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA
- Patient advocate: Mr Scott Wilson, Denver, CO, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/